STREAM: a pragmatic and explanatory trial for MDR-TB treatment
Lancet Infect Dis
.
2019 Jun;19(6):575-576.
doi: 10.1016/S1473-3099(19)30215-4.
Authors
Ibrahim Abubakar
1
,
Sarah Meredith
2
,
Andrew J Nunn
2
,
Patrick P J Phillips
3
,
I D Rusen
4
Affiliations
1
Institute for Global Health, University College London, London WC1N 1EH, UK. Electronic address: i.abubakar@ucl.ac.uk.
2
Medical Research Council Clinical Trials Unit, University College London, London WC1N 1EH, UK.
3
School of Medicine, UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
4
Division of Research and Development, Vital Strategies, New York, NY, USA.
PMID:
31122769
DOI:
10.1016/S1473-3099(19)30215-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents
Humans
Myocardial Infarction*
Tuberculosis, Multidrug-Resistant*
Substances
Antitubercular Agents
Grants and funding
MC_UU_12023/27/MRC_/Medical Research Council/United Kingdom